Menu

• Ask a Health Expert about MICROANGIOPATHIC HAEMOLYTIC ANAEMIA
• Post Your Side Effect related to MICROANGIOPATHIC HAEMOLYTIC ANAEMIA
• MICROANGIOPATHIC HAEMOLYTIC ANAEMIA and FDA Warnings
• MICROANGIOPATHIC HAEMOLYTIC ANAEMIA in Patients Wiki
• Report MICROANGIOPATHIC HAEMOLYTIC ANAEMIA in Drug Side Effect Survey

MICROANGIOPATHIC HAEMOLYTIC ANAEMIA side effect

What is MICROANGIOPATHIC HAEMOLYTIC ANAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Gleevec Side Effects Report #5653927-7
Physician from SPAIN reported GLEEVEC problem on Feb 27, 2008. Male patient, 36 years of age, was diagnosed with acute lymphocytic leukaemia, stem cell transplant and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, platelet count decreased, . GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with SANDIMMUNE. Patient recovered.

Sutent Side Effects Report #5689382-0
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, 57 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . SUTENT dosage: DAILY DOSE:50MG. During the same period patient was treated with AVASTIN, LORAZEPAM, ASCORBIC ACID, VITAMIN CAP, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5689420-5
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Mar 19, 2008. Female patient, 76 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.

Bevacizumab Side Effects Report #5633812-7
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Female patient, 57 years of age, was diagnosed with renal cell carcinoma, insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5634009-7
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.

Bevacizumab Side Effects Report #5634660-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Female patient, 76 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.

Doxil Side Effects Report #5578664-9
Physician from UNITED STATES reported DOXIL problem on Dec 26, 2007. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . DOXIL dosage: unknown. During the same period patient was treated with VELCADE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5586978-1
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.

Bevacizumab Side Effects Report #5592279-8
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.


Doxil Side Effects Report #5564887-1
DOXIL problem was reported by a Physician from UNITED STATES on Dec 10, 2007. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, . DOXIL dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.

Velcade Side Effects Report #5574508-X
Physician from UNITED STATES reported VELCADE problem on Dec 10, 2007. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, platelet count decreased, . VELCADE dosage: unknown. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.

Novonorm Side Effects Report #5452580-5
NOVONORM problem was reported by a Physician from FRANCE on Sept 06, 2007. Female patient, 87 years of age, weighting 154.3 lb, was diagnosed with arrhythmia, hypertension, gout and was treated with NOVONORM. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, vasculitis, . NOVONORM dosage: 1.5 MG, QD. During the same period patient was treated with PREVISCAN, FLECAINIDE ACETATE, BISOPROLOL, IRBESARTAN, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Novonorm Side Effects Report #5417964-X
Physician from FRANCE reported NOVONORM problem on Aug 07, 2007. Female patient, 87 years of age, weighting 176.4 lb, was treated with NOVONORM. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, vasculitis, . NOVONORM dosage: 1.5 MG, QD. Patient was hospitalized. Patient recovered.

Protopic Side Effects Report #5757747-4
PROTOPIC problem was reported by a Pharmacist from UNITED KINGDOM on May 13, 2008. Female patient, child 5 years of age, was diagnosed with graft versus host disease and was treated with PROTOPIC. After drug was administered, patient experienced the following problems/side effects: anaemia, microangiopathic haemolytic anaemia, serum ferritin decreased, thrombotic microangiopathy, . PROTOPIC dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.


Rapamune Side Effects Report #5453994-X
Physician from CANADA reported RAPAMUNE problem on Sept 13, 2007. Female patient, weighting 109.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, candida sepsis, microangiopathic haemolytic anaemia, multi-organ failure, . RAPAMUNE dosage: VARIED DOSE OF 2 TO 5 MG. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CORTICOSTEROID NOS, ZENAPAX. Patient was hospitalized. Patient died on 12/19/2004.

Myfortic Side Effects Report #5761236-0
MYFORTIC problem was reported by a Physician from SPAIN on June 03, 2008. Female patient was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney, graft complication, microangiopathic haemolytic anaemia, nephropathy toxic, renal tubular necrosis, thrombocytopenia, . MYFORTIC dosage: unknown. During the same period patient was treated with TACROLIMUS COMP, TACROLIMUS COMP. Patient was hospitalized. Patient recovered.

Myfortic Side Effects Report #5754110-7
Physician from SPAIN reported MYFORTIC problem on May 28, 2008. Female patient was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney, graft complication, microangiopathic haemolytic anaemia, nephropathy toxic, renal tubular necrosis, thrombocytopenia, . MYFORTIC dosage: unknown. During the same period patient was treated with TACROLIMUS COMP, TACROLIMUS COMP. Patient was hospitalized. Patient recovered.